Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...

Sanofi Pasteur said it’s discontinuing the manufacture of TheraCys, an important bladder cancer drug, and shortages are expected, while the US Food and Drug Administration (FDA) on Friday released ...

The FDA has approved Inlexzo, the first intravesical drug-releasing device for bladder cancer, offering an alternative for patients whose disease no longer responds to BCG therapy. The device delivers ...

While the method may sound unfamiliar, it has been clinically validated for decades and remains central to preventing ...

Doctors consider surgery for interstitial cystitis (IC) as a last resort when other treatments, such as diet changes, medications, bladder instillations, and physical therapy, have failed to bring ...